4-Methoxyphenyl 2,6-Bis-O-(4-methylbenzoyl)-beta-D-galactopyranoside>98.0%(HPLC)1g

N-Acetyl-L-isoleucine, 95.0%, 100g

GC capillary column ROTI®Cap-1, 25 m, 0.53 mm, 2.00 µm, 1 Piece(s)

(S)-3-((TERT-BUTOXYCARBONYL)AMINO)-4-(3-(TRIFLUOROMETHYL)PHENYL)BUTANOIC ACID, 95%, 1g

4-Chloro-6-methyl-1H-pyrrolo[3,2-c]pyridine, 95.0%, 250mg

LacDiNAc MP Glycoside>95.0%(HPLC)5mg

2-Ethylbenzo[d]oxazole, 97.0%, 10g

2-Nonyl-1H-benzo[d]imidazole, 95+%, 5g

2-(Dimethylamino)ethanol>99.0%(GC)(T)500mL

1-(3-Methoxyphenyl)-1H-pyrazole-4-carboxylic acid, 1g

9-(2,4-DIHYDROXYPHENYL)-3,3,6,6-TETRAMETHYL-3,4,5,6,7,9-HEXAHYDRO-1H-XANTHENE-1,8(2H)-DIONE, 95%, 250mg

3,4-Dimethoxy-2-methylpyridine, 97.0%, 1g

N,N,2-Trimethyl-5-nitrobenzenesulfonamide, 98.0%, 250mg